The Venture Codex Logo

The Venture Codex

LYFE Capital

6 Battery Road, #28-02, Singapore, 049909

Overview

Healthcare-focused investment firm advancing global healthcare solutions.

Founded

2015

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

China
France
United States

Sector focus

Biotechnology

Investment portfolio

28rounds
NAMEDATESIZE
Aspen Neuroscience
Nov 2025Participated
$115 MSeries C
Verdiva Bio
Jan 2025Participated
$411 MSeries A
CytoTronics
Sep 2024Led
$14 MSeed
ProfoundBio
Feb 2024Participated
$112 MSeries B
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
Kyverna Therapeutics
Aug 2023Participated
$60 MSeries B
Noah Medical
Apr 2023Participated
$150 MSeries B
iECURE
Nov 2022Led
$65 MSeries A
MobiDrop
Jul 2022Led
$15 MSeries A
Aspen Neuroscience
May 2022Led
$148 MSeries B
Medilink Therapeutics
Mar 2022Led
$70 MSeries B
Kyverna Therapeutics
Jan 2022Participated
$85 MSeries B
Aspen Neuroscience
Nov 2025Participated
$115 MSeries C
Verdiva Bio
Jan 2025Participated
$411 MSeries A
CytoTronics
Sep 2024Led
$14 MSeed
ProfoundBio
Feb 2024Participated
$112 MSeries B
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
Kyverna Therapeutics
Aug 2023Participated
$60 MSeries B
Noah Medical
Apr 2023Participated
$150 MSeries B
iECURE
Nov 2022Led
$65 MSeries A
MobiDrop
Jul 2022Led
$15 MSeries A
Aspen Neuroscience
May 2022Led
$148 MSeries B
Medilink Therapeutics
Mar 2022Led
$70 MSeries B
Kyverna Therapeutics
Jan 2022Participated
$85 MSeries B
28
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

LYFE Capital: 28 funding rounds are recorded in the selected participation categories.All available history.
LYFE Capital: 28 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A23
Series B47
Series C+36
Other Equity02

Monthly Deal Activity

LYFE Capital: 28 deals are recorded across 102 months.All available history.
LYFE Capital: 28 deals are recorded across 102 months. All available history
MonthDeals
May '182
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '191
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '191
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '201
Nov '201
Dec '202
Jan '211
Feb '212
Mar '210
Apr '212
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '211
Nov '210
Dec '210
Jan '222
Feb '220
Mar '221
Apr '220
May '221
Jun '220
Jul '221
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

LYFE Capital: Health & Life Sciences is the largest displayed sector by deal count (27 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

LYFE Capital: Health & Life Sciences is the largest displayed sector by deal count (27 deals). All available history
SectorDeals
Health & Life Sciences27
Manufacturing3
Space & Frontier Tech3
Data, Analytics & IT1

Deal Size Distribution

LYFE Capital: 28 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

LYFE Capital: 28 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M4
$25M-$50M4
$50M-$100M11
$100M-$250M8
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

LYFE Capital: United States has the largest recorded deal count among the displayed regions (15 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

LYFE Capital: United States has the largest recorded deal count among the displayed regions (15 deals). All available history
RegionDeals
United States15
China9
Europe3
Israel1
LYFE Capital: 20 co-investors are shown, with OrbiMed sharing 7 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

LYFE Capital: 20 co-investors are shown, with OrbiMed sharing 7 recorded deals. All available history
Co-investorShared deals
OrbiMed7
Lilly Asia Ventures6
RA Capital Management5
Hongshan Capital Group (Sequoia Capital China)4
Alexandria Venture Investments3
Cormorant Asset Management3
IDG Capital3
Legend Star3
VI Ventures3
ARCH Venture Partners2
BlackRock2
CAM Capital2
Frazier Life Sciences2
Gilead Sciences2
Hillhouse Capital Group2
Hudson Bay Capital2
Insight Partners2
jVen Capital2
Kite2
Legend Capital2

Investment Strategy

LYFE Capital: Led accounts for 36% and participating for 64% of round participation.All available history.
LYFE Capital: Led accounts for 36% and participating for 64% of round participation. All available history
CategoryDeals (count)Share (%)
Led1036%
Participating1864%
LYFE Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
LYFE Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead550%
Co-led550%

Team

James Zhao

Co founder

Roy Xu

CFO

Wang Yinan

Partner